Abstract
Insulin action on target tissues is mediated by specific tyrosine kinase receptors. Upon ligand binding insulin receptors autophosphorylate and phosphorylate intracellular substrates on tyrosine residues. These early events of insulin action are followed by the activation of a number of enzymes, including protein kinase C (PKC). At least 14 PKC isoforms have been identified and cloned to date. PKCs appear to play dual roles in insulin signaling. For instance, they are involved in transduction of specific insulin signals but also contribute to the generation of insulin resistance. In this article, we will analyze the experimental evidence addressing the mechanism by which insulin might activate individual PKC isoforms as well as the role of single PKCs in insulin-induced bioeffects.
Similar content being viewed by others
References
Virkamaki A., Ueki K., Kahn. C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 1999, 103: 931–943.
White M.F. The insulin signalling system and the IRS proteins. Diabetologia 1997, 40 (Suppl. 2): S2–S17.
Farese R.V., Standaert M.L., Arnold T., Yu B., Ishizuka T., Hoffman J., Vila M., Cooper D.R. The role of protein kinase C in insulin action. Cell Signal. 1992, 4: 133–143.
Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem. J. 1998, 332: 281–292.
Newton A.C. Regulation of protein kinase C. Curr. Opin. Cell Biol. 1997, 9: 161–167.
Jaken S. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 1996, 8: 168–173.
Nakanishi H., Brewer K.A., Exton J.H. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1993, 268: 13–16.
Blackshear P.J. The role (or lack thereof) of protein kinase C in insulin action. In: Draznin B., LeRoith D. (Eds.) Molecular biology of diabetes, Part II. Humana Press Inc., Totowa, NJ 1994, p. 229.
Formisano P., Oriente F., Fiory F., Caruso M., Miele C., Maitan A., Andreozzi F., Vigliotta G., Condorelli G., Beguinot F. Insulin-activated PKCbeta bypasses Ras and stimulates MAP kinase activity and cell proliferation in muscle cells. Mol. Cell. Biol. 2000, 20: 6323–6333.
Donchenko V., Zannetti A., Baldini P.M. Insulin-stimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes. Biochim. Biophys. Acta 1994, 1222: 492–500.
Kayali, A. G., Eichhorn J., Haruta T., Morris A. J., Nelson J. G., Vollenweider P., Olefsky J.M., Webster N.J. Association of the insulin receptor with phospholi-pase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin. J. Biol. Chem. 1998, 273: 13808–13818.
Seedorf K., Juhl L., Hansen L., Nielsen L., Mosthaf L. Insulin-induced activation of MAP kinase involves GRB2, SHPT2, PI3 kinase and PLC-gamma. Exp. Clin. Endocrinol. Diabetes 1995, 104 (Suppl. 2): 138.
Standaert M.L., Bandyopadhyay G., Zhou X., Galloway L., Farese R.V. Insulin stimulates phospholipase D-dependent phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes. Endocrinology 1996, 137: 3014–3020.
Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phospho-inositide 3-kinase through the protein kinase PDK1. Science 1998, 281: 2042–2045.
Dong L.Q., Landa L.R., Wick M.J., Zhu L., Mukai H., Ono Y., Liu F. Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton. Proc. Natl. Acad. Sci USA 2000, 97: 5089–5094.
Standaert, M.L., Galloway L., Karnam P., Bandyo-padhyay G., Moscat J., Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 1997, 272: 30075–30082.
Seedorf K., Shearman M., Ullrich A. Rapid and long-term effects on protein kinase C on receptor tyrosine kinase phosphorylation and degradation. J. Biol. Chem. 1995, 270: 18953–18960.
Formisano P., Oriente F., Miele C., Caruso M., Auricchio R., Vigliotta G., Condorelli G., Beguinot F. NIH3T3 fibroblasts, insulin receptor interaction with specific protein kinase isoforms controls receptor in-tracellular routing. J. Biol. Chem. 1998, 273: 13197–13202.
Liu F., Roth R.A. Insulin-stimulated tyrosine phosphorylation of protein kinase C alpha: evidence for direct interaction of the insulin receptor and protein kinase C in cells. Biochem. Biophys. Res. Commun. 1994, 200: 1570–1577.
Braiman L., Sheffi-Friedman L., Bak A., Tennenbaum T., Sampson S.R. Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle. Diabetes. 1999, 48: 1922–1929.
Braiman L., Alt A., Kuroki T., Ohba M., Bak A., Tennenbaum T., Sampson S.R. Protein kinase Cdelta mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle. Mol. Endocrinol. 1999, 13: 2002–2012.
Bossenmaier B., Mosthaf L., Mischak H., Ullrich A., Haring H.U. Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 1997, 40: 863–866.
Borner C., Ueffing M., Jaken S., Parker P.J., Weinstein I.B. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibrob-lasts. Possible molecular mechanisms. J. Biol. Chem. 1995, 270: 78–86.
Chalfant C.E., Ohno S., Konno Y., Fisher A.A., Bisnauth L.D., Watson J.E., Cooper D.R. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol. Endocrinol. 1996, 10: 1273–1281.
Chin J.E., Dickens M., Tavare J. M., Roth R.A. Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J. Biol. Chem. 1993, 268: 6338–6347.
Chin J.E., Liu F., Roth R.A. Activation of protein kinase C alfa inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol. Endocrinol. 1994, 8: 51–58.
Caruso M., Miele C., Oriente F., Maitan A., Bifulco G., Andreozzi F., Condorelli G., Formisano P., Beguinot F. In L6 skeletal muscle cells, glucose induces cytoso-lic translocation of protein kinase C alfa and trans-activates the insulin receptor kinase. J. Biol. Chem. 1999, 274: 28637–28644.
Berti L., Mosthaf L., Kroder G., Kellerer M., Tippmer S., Mushack J., Seffer E., Seedorf K., Haring H. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J. Biol. Chem. 1994, 269: 3381–3386.
Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47: 859–866.
Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., King G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996, 272: 728–731.
Chalfant C.E., Mischak H., Watson J.E., Winkler B.C., Goodnight J., Farese R.V., Cooper D.R. Regulation of alternative splicing of protein kinase C beta by insulin. J. Biol. Chem. 1995, 270: 13326–32.
Standaert, M.L., Bandyopadhyay G., Galloway L., Soto J., Ono Y., Kikkawa U., Farese R.V., Leitges M. Effects of knockout of the protein kinase C beta gene on glucose transport and glucose home-ostasis. Endocrinology 1999, 140: 4470–4477.
Nakajima K., Yamauchi K., Shigematsu S., Ikeo S., Komatsu M., Aizawa T., Hashizume K. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J. Biol. Chem. 2000, 275: 20880–20886.
Chalfant C.E., Ciaraldi T.P., Watson J.E., Nikoulina S., Henry R.R., Cooper D.R. Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dys-regulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity. Endocrinology 2000, 141: 2773–2778.
Itani S.I., Zhou Q., Pories W.J., MacDonald K.G., Dohm G.L. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000, 49: 1353–1358.
Kellerer M., Mushack J., Seffer E., Mischak H., Ullrich A., Haring H.U. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the ty-rosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 1998, 41: 833–838.
Strack V., Hennige A.M., Krutzfeldt J., Bossenmaier B., Klein H.H., Kellerer M., Lammers R., Haring H.U. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinaseC isoforms beta2 and theta. Diabetologia 2000, 43: 443–449.
Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48: 1270–1274.
Donnelly R., Reed M.J., Azhar S., Reaven G.M. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 1994, 135: 2369–2374.
Bandyopadhyay G., Standaert M.L., Galloway L., Moscat J., Farese R.V. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 1997, 138: 4721–4731.
Kotani K., Ogawa W., Matsumoto M., Kitamura T., Sakaue H., Hino Y., Miyake K., Sano W., Akimoto K., Ohno S., Kasuga M. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell Biol. 1998, 18: 6971–6982.
Uberall F., Hellbert K., Kampfer S., Maly K., Villunger A., Spitaler M., Mwanjewe J., Baier-Bitterlich G., Baier G., Grunicke H.H. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-me-diated reorganization of the F-actin cytoskeleton. J. Cell Biol. 1999, 144: 413–425.
Bandyopadhyay G., Standaert M.L., Kikkawa U., Ono Y., Moscat J., Farese R.V. Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda. Biochem J. 1999, 337: 461–470.
Standaert M.L., Bandyopadhyay G., Perez L., Price D., Galloway L., Poklepovic A., Sajan M.P., Cenni V., Sirri A., Moscat J., Toker A., Farese R.V. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J. Biol. Chem. 1999, 274: 25308–25316.
Kotani K., Ogawa W., Hashiramoto M., Onishi T., Ohno S., Kasuga M. Inhibition of insulin-induced glucose uptake by atypical protein kinase C isotype-specific interacting protein in 3T3-L1 adipocytes. J. Biol. Chem. 2000, 275: 26390–26395.
Ravichandran L.V., Esposito D.L., Chen J., Quon M.J. PKC-{zeta} phosphorylates IRS-1 and impairs its ability to activate PI 3-kinase in response to insulin. J. Biol. Chem. 2000, [epub ahead of print].
Mendez R., Kollmorgen G., White M.F., Rhoads R.E. Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin. Mol. Cell. Biol. 1997, 17: 5184–5192.
Sauvage M., Maziere P., Fathallah H., Giraud F. Insulin stimulates NHE1 activity by sequential activation of phosphatidylinositol 3-kinase and protein kinase C zeta in human erythro-cytes. Eur. J. Biochem. 2000, 267: 955–962.
Sweeney G., Somwar R., Ramlal T., Martin-Vasallo P., Klip A. Insulin stimulation of K+ uptake in 3T3-L1 fibrob-lasts involves phosphatidylinositol 3-kinase and protein kinase C-zeta. Diabetologia 1998, 41: 1199–1204.
Sajan M.P., Standaert M.L., Bandyopadhyay G., Quon M.J., Burke T.R., Farese R.V. Protein kinase C-zeta and phosphoinositides-dependent protein kinase-1 are required for insulin-induced activation of ERK in rat adipocytes. J. Biol. Chem. 1999, 274: 30495–30500.
Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C.P., Alessi D.R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol. 1999, 9: 393–404.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Formisano, P., Beguinot, F. The role of protein kinase C isoforms in insulin action. J Endocrinol Invest 24, 460–467 (2001). https://doi.org/10.1007/BF03351048
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351048